Real-world experience with GLP-1 receptor agonists in adults with epilepsy following a modified atkins diet
- 14 August 2026
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 227, 107896
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Very low‐calorie ketogenic diet and liraglutide as a synergistic strategy for the treatment of obesity: A short‐term, non‐randomised, observational, real‐world clinical evaluationDiabetes, Obesity and Metabolism, 2025
- Newer glucose‐lowering drugs reduce the risk of late‐onset seizure and epilepsy: A meta‐analysisEpilepsia Open, 2024
- Adherence to ketogenic dietary therapies in epilepsy: A systematic review of literatureNutrition Research, 2024
- Predictors of elevations in fasting lipid levels in adults with epilepsy on a modified Atkins dietSeizure: European Journal of Epilepsy, 2023
- A Comparative Review of Established Diets for Prevention of Cardiovascular Disease and Newer Dietary StrategiesCurrent Problems in Cardiology, 2021
- Six-month effects of modified Atkins diet implementation on indices of cardiovascular disease risk in adults with epilepsyNutritional Neuroscience, 2021
- Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant EpilepsyJAMA Pediatrics, 2020
- Improving compliance in adults with epilepsy on a modified Atkins diet: A randomized trialSeizure: European Journal of Epilepsy, 2018
- A decade of the modified Atkins diet (2003–2013): Results, insights, and future directionsEpilepsy & Behavior, 2013
- Neuroprotective and disease-modifying effects of the ketogenic dietBehavioural Pharmacology, 2006